Exicure, Inc.
NASDAQ: XCUR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jungsoo Kim
- Employees
- 7
- Headquarters
- Chicago, United States
- IPO year
- 2018
- Market cap
- $17.1M
- Website
- https://www.exicuretx.com
Loading XCUR…
Loading profile data…Frequently asked questions about XCUR
What does Exicure, Inc. (XCUR) do?
Exicure, Inc. is a biotechnology firm that utilizes its unique spherical nucleic acid (SNA) platform to create therapies for neurological conditions and hair loss. Its primary experimental candidate, SCN9A, is currently undergoing preclinical evaluation for addressing neuropathic and chronic pain. The company has entered into a strategic partner...
Where does XCUR trade?
Exicure, Inc. (XCUR) trades on the NASDAQ Capital Market.
What sector is XCUR in?
Exicure, Inc. (XCUR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Exicure, Inc.?
Jungsoo Kim is the chief executive officer of Exicure, Inc. (XCUR).
Where is Exicure, Inc. headquartered?
Exicure, Inc. is headquartered in United States.
Does XCUR pay a dividend?
Exicure, Inc. (XCUR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did XCUR go public?
Exicure, Inc. (XCUR) completed its initial public offering in 2018.